Budget impact analysis: comparing the costs of nusinersen and risdiplam in the treatment of type 3 spinal muscular atrophy patients

Authors

Keywords

Journal

Volume -, Issue -, Pages ejhpharm-2023-003733

Publisher

BMJ

Online

2023-10-29

DOI

10.1136/ejhpharm-2023-003733

References

View 4 related references

Explore over 38,000 international journals covering a vast array of academic fields.

Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.

Create Now